NutriBand (NTRB) Finished Goods (2018)

NutriBand's (NTRB) quarterly Finished Goods came in at $4133.0 in Q4 2018, little changed quarter-over-quarter from $4133.0 in Q3 2018.

NutriBand (NTRB) Finished Goods (2018) Analysis & Trends

NutriBand has disclosed Finished Goods across 1 years of filings, most recently posting $4133.0 for Q4 2018.

Finished Goods for Q4 2018 came in at $4133.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2018 was $4133.0 (changed N/A YoY), and the FY2018 annual result was $4133.0, changed N/A from the prior year.
Finished Goods came in at $4133.0 for Q4 2018 at NutriBand, roughly flat from $4133.0 in the prior quarter.
In the past five years, Finished Goods ranged from a high of $4133.0 in Q1 2018 to a low of $4133.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	NutriBand	41.91 Mn	37.33 Mn	88,941.00

Download Data